Skip to main content
SpringerLink
Log in

Sanofi recalling epinephrine injection device

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sanofi. Sanofi Canada Issues Voluntary Nationwide Recall of Allerject(R) Due to Potential Inaccurate Dosage Delivery. Media Release : 28 Oct 2015. Available from: URL: http://www.sanofi.ca..

  2. Advisory - Sanofi recalls all lots of Allerject (0.15 mg/0.15 mL and 0.3 mg/0.3 mL strengths of epinephrine auto-injectors). Media Release : 28 Oct 2015. Available from: URL: http://www.hc-sc.gc.ca..

  3. FDA. Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery. Internet Document : 29 Oct 2015. Available from: URL: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm470010.htm..

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanofi recalling epinephrine injection device. Reactions Weekly 1577, 6 (2015). https://doi.org/10.1007/s40278-015-10419-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-015-10419-8

Search

Navigation